Paul van Slyke
Chief Tech/Sci/R&D Officer bij PHARMADRUG INC.
Profiel
Paul van Slyke is currently the Chief Scientific Officer at Pharmadrug, Inc. He previously held the same position at Vasomune Therapeutics, Inc. and Sairiyo Therapeutics, Inc. He obtained a doctorate degree from the University of Toronto.
Actieve functies van Paul van Slyke
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARMADRUG INC. | Chief Tech/Sci/R&D Officer | 13-05-2021 |
Eerdere bekende functies van Paul van Slyke
| Bedrijven | Functie | Einde |
|---|---|---|
Sairiyo Therapeutics, Inc.
 Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pharmadrug, Inc., Sairiyo Therapeutics, Inc. is a Canadian company that manufactures and sells pharmaceutical products. Sairiyo Therapeutics was acquired by Pharmadrug, Inc. | Chief Tech/Sci/R&D Officer | - |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Paul van Slyke
| University of Toronto | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PHARMADRUG INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Sairiyo Therapeutics, Inc.
Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Pharmadrug, Inc., Sairiyo Therapeutics, Inc. is a Canadian company that manufactures and sells pharmaceutical products. Sairiyo Therapeutics was acquired by Pharmadrug, Inc. | Health Technology |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Health Technology |
